MLYS icon

Mineralys Therapeutics

77 hedge funds and large institutions have $252M invested in Mineralys Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$14M
2 +$5.41M
3 +$4.35M
4
Millennium Management
Millennium Management
New York
+$3.46M
5
LCM
Laurion Capital Management
New York
+$2.76M

Top Sellers

1 -$14.3M
2 -$13.1M
3 -$9.31M
4
Jennison Associates
Jennison Associates
New York
-$6.06M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$1.51M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.28M
27
$1.19M
28
$1.06M
29
$1.01M
30
$910K
31
$409K
32
$386K
33
$384K
34
$357K
35
$343K
36
$311K
37
$287K
38
$214K
39
$212K
40
$182K
41
$178K
42
$177K
43
$163K
44
$151K
45
$145K
46
$132K
47
$126K
48
$108K
49
$96.8K
50
$95.7K